India's first vaccine against cervical cancer

Serum Institute develops India's first vaccine against cervical cancer

Serum Institute of India (SII) has applied to the country's drug regulator seeking market authorisation to manufacture indigenously developed India's first Quadrivalent Human Papillomavirus